LabMinds Announces Anita Santos Named as Vice President of Marketing

BOSTON: LabMinds, Inc., a next-generation robotics company focused on solution preparation, announces that Anita Santos has been named as Vice President of Marketing. Anita brings over 12 years of experience in the life science industry with a history of success in marketing, strategy and product management, including more than 20 years of business-to-business marketing experience. [...]

Numinus Wellness Forges Forward into Psychedelic Discovery Research with the Orbitrap Exploris 120 Mass Spectometer

Acquisition of industry-leading instrument by Thermo Fisher Scientific will significantly advance psychedelic research and accelerate third-party standardized testing capabilities VANCOUVER, BC, Jan. 13, 2021 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI ), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of [...]

Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform

MENLO PARK, Calif. -- Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced a multi-year collaboration with Invitae Corporation (NYSE: NVTA), a leading medical genetics company, to begin development of a production-scale high-throughput sequencing platform leveraging the power of PacBio’s highly accurate HiFi sequencing to expand Invitae’s [...]

Oxford Nanopore and NVIDIA collaborate to partner the DGX AI compute system with ultra-high throughput PromethION sequencer

Oxford Nanopore Technologies and NVIDIA are collaborating this year to integrate the NVIDIA DGX Station A100 into Oxford Nanopore’s ultra-high throughput sequencing system, PromethION.  Partnering the NVIDIA A100 Tensor Core GPU technology with the PromethION device aims to deliver the world’s most powerful sequencer that supports real-time analyses at scale, and can also analyse any [...]

Personal Genome Diagnostics and QIAGEN Collaborate to Offer Integrated Genomic Testing and Interpretation Support

Partnership to Accelerate Adoption of Next-Generation Sequencing (NGS) in Clinical Decision-Making Comprehensive Pan-Cancer Tumor Profiling Assays can be Combined with Clinical Informatics Platform with Potential to Reduce Time to Results and Complexity of Clinical Genomic Analysis Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, announced today that it has entered into a collaboration [...]

NanoView Biosciences Strengthens Executive Team

BOSTON -- NanoView Biosciences, Inc., the leader in single exosome characterization, today announced the expansion of its management team with the appointment of David Hanlon, Ph.D. to the position of Vice President, Strategic Collaborations.   The addition is a key part of the company's strategy to create and expand strategic partnerships within the life sciences, pharmaceutical and diagnostics [...]

SFW Capital Completes Strategic Recapitalization of Caron Products and Services

Growth-Oriented Private Equity Firm SFW Partners with Leading Provider of Laboratory Equipment to Drive Growth Through Expansion of Product Portfolio and Strategic Acquisitions RYE, N.Y. – SFW Capital Partners (“SFW”), a specialized private equity firm that invests in leading providers of instrumentation, laboratory products, software/information and related solutions, today announced that it has completed a [...]

Nanalysis Scientific Corp. Signs Strategic OEM Partnership for Magnetic Resonance Electronics Sales

CALGARY, AB - Nanalysis Scientific Corp. ("Nanalysis"),((NSCI) ((NSCIF) (FRA: 1N1), through its subsidiary RS2D S.A.S. ("RS2D"), is pleased to announce that it has signed multi-million dollar OEM and licensing deal with a European corporation. Rémy Schimpf, Senior VP Sales states "The deal includes an initial payment of roughly $1 million, and a further $2 million in milestone payments over the next [...]

BD Advances Immunology Research by Enabling Researchers to Investigate 30 Immune Markers in a Single Experiment

The BD® AbSeq Immune Discovery Panel enables researchers to execute single cell experiments with high efficiency FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of the BD® AbSeq Immune Discovery Panel (IDP), a state-of-the-art, pre-titrated antibody-oligo based discovery tool designed to investigate 30 immune [...]

Jumpcode Genomics Secures $21M in Series B Funding

Investors include Baird Capital, Arboretum Ventures and LYZZ Capital; funding will accelerate commercialization of CRISPRclean™ next-generation sequencing technology Life sciences industry veteran Frank Witney joins Jumpcode Board of Directors Jumpcode opens new headquarters in San Diego biotech business hub SAN DIEGO, Calif. – Jumpcode Genomics – a genome technology company focused on improving the understanding of human [...]

Access IBO on Knowledge Center
Register to Subscribe Login for Access

Register to Subscribe Login for Access

Lost your password? Register